Learn how Johnson & Johnson Innovative Medicine is transforming the future of healthcare and leading where medicine is going.
Learn how Johnson & Johnson Innovative Medicine is transforming the future of healthcare and leading where medicine is going.
Learn how Johnson & Johnson Innovative Medicine is transforming the future of healthcare and leading where medicine is going.
President, Oncology, Johnson & Johnson Innovative Medicine. “We intend to lead where hematology is going so patients can ultimately live longer, better lives.” Accelerating innovative therapies across all lines of treatment in multiple...
Acquisition strengthens Johnson & Johnson’s commitment to innovation in prostate cancer and deepens pipeline of next-generation antibody drug conjugates and targeted oncologic therapeutics
Learn how Johnson & Johnson Innovative Medicine is transforming the future of healthcare and leading where medicine is going.
Learn how Johnson & Johnson Innovative Medicine is transforming the future of healthcare and leading where medicine is going.
Learn how Johnson & Johnson Innovative Medicine is transforming the future of healthcare and leading where medicine is going.
Learn how Johnson & Johnson Innovative Medicine is transforming the future of healthcare and leading where medicine is going.
The integration of Ambrx’s ADC technology into J&J’s portfolio presents a unique opportunity to advance the development and commercialisation of targeted oncology therapies. J&J will gain access to the Ambrx pipeline comprising candidate therapeutics for a range of cancer indications. ...